CONTROLLED DELIVERY OF ANTIRETROVIRAL DRUG-LOADED CROSS-LINKED MICROSPHERES BY IONIC GELATION METHOD
DOI:
https://doi.org/10.22159/ajpcr.2016.v9i5.13653Abstract
Objective: Lamivudine (LVD) is a nucleoside reverse transcriptase inhibitor originally developed as an antiretroviral drug and primarily used in the
treatment of most common chronic disease of the planet, acquired immune deficiency syndrome and hepatitis B. The main objective of the study is to
develop controlled drug delivery system to increase the efficacy of antiretroviral drug, LVD against human immunodeficiency virus infections.
Methods: The microencapsulation of LVD in gelatin microspheres was carried out by cross-linking process with glutaraldehyde saturated toluene
using ionic-gelation method. The prepared microspheres were evaluated for particle size analysis, % yield value, % drug content, drug entrapment
efficiency, scanning electron microscopy for surface morphology, swelling index, accelerated stability studies, Fourier transform infrared radiation
spectroscopy (FT-IR) and differential scanning calorimetry (DSC) for polymer drug compatibility, in vitro dissolution efficiency and release kinetic
studies.
Results: The obtained microspheres showed very smooth surface and exhibited regular spherical geometry due to higher crosslinking density. FT-IR
and DSC revealed the absence of drug polymer interactions. The percentage yield, entrapment efficiency and drug content for F6 LVD microspheres
was found to be 79.31%, 65.55% and 96.25% respectively. The particle size was ranged from 34.61% to 51.45 μm sizes and in vitro release profile
showed that cross-linking density of gelatin microspheres effectively controlled the release of LVD.
Conclusion: The findings of our investigation demonstrated that F6 of gelatin-LVD microspheres had good controlled release profile with maximum
entrapment efficiency and prolonged drug release for 24 hrs or longer and this formulation would be capable of overcoming the drawbacks and
limitations of LVD conventional dosage forms.
Keywords: Lamivudine, Microspheres, Controlled release, Gelatin, Fourier transform infrared, Differential scanning calorimetry, In vitro release
kinetics.
Downloads
References
Prakash K, Raju PN, Shanta KK, Lakshmi MN. Preparation and characterization of lamivudine microcapsules using various cellulose polymers. Trop J Pharm Res 2007;6(4):841-7.
Perry CM, Faulds D. Lamivudine-A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs 1997;53(4):667-80. Fig. 9: Comparative in vitro release profile of liver venous deprivation microspheres Fig. 10: Accelerated stability studies for F6
Over M, Heywood P, Gold J, Gupta I, Hira S, Marseille E. Treatment and Prevention in India Modeling the Cost and Consequences. Washington, D.C: The International Bank for Reconstruction and Development/The World Bank; 2004. p. 14.
Pradeep B, Nagamadhu M, Banji D, Madhavi BB, Arjun G, Shekhar K. Formulation and evaluation of valaciclovir hydrochloride microcapsules. Int J Pharm Pharm Sci 2011;3(2):92-6.
Merrill DP, Moonis M, Chou TC, Hirsch MS. Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus Type 1 replication in vitro. J Infect Dis 1996;173(2):355-64.
Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, et al. Phosphorylation of 3′-azido-3′-eoxythymidine and selective interaction of the 5′-riphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A 1986;83(21):8333-7.
Amitava G, Udaya Kumar N, Partha R. Development, evaluation and method selection for the preparation of lamivudine microspheres. Int J Pharm Pharm First Published June; 2007. Available from: http://www.priory.com.
Ghosh A, Nayak UK, Roy P. Development, evaluation and method selection for the preparation of lamivudine microspheres. Int J Pharm 2007;9:67-71.
Zhang C, Cheng Y, Qu G, Wu X, Ding Y, Cheng Z, et al. Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil. Carbohydr Polym 2008;72(3):390-7.
Gibaldi M. Controlled drug delivery systems. In: Biopharmaceutics and Clinical Pharmacokinetics. 3rd ed. Philadelphia, PA: Lea and Febiger; 1987. p. 129-85.
Chien YW. Controlled and modulated release drug delivery systems. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker Inc.; 1990. p. 280-5.
Dhanaraju MD, Kumar RM, Nithya P, Kishan JV, Thirumurugan G. Controlled delivery of antiretroviral drug loaded chitosan cross-linked microspheres. Arch Appl Sci Res 2009;1(2):279-86.
Parvathi M, Prathyusha A, Kiran RS, Reddy RJ. Preparation and evaluation of quetiapine fumarate microemulsions: A novel delivery system. Asian J Pharm Clin Res 2014;7(2):208-13.
Kavitha K, Pavanveena C, Anil Kumar SN, Tamizh Mani T. Formulation and evaluation of trimetazidine hydrochloride loaded gelatin microspheres. Int J Pharm Pharm Sci 2010;3(2):67-70.
Joshi JR, Patel RP. Role of biodegradable polymers in drug delivery. Int J Curr Pharm Res 2012;4(4):74-81.
Arunachalam A, Rathinaraj BS, Subramanian, Choudhury PK, Reddy KA, Fareedullah MD. Preparation and evaluation of ofloxacin microspheres using natural gelatin polymer. Int J Appl Biol Pharm Technol 2010;1(1):61-7.
Pérez-Rodriguez C, Montano N, Gonzalez K, Griebenow K. Stabilization of α-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. J Control Release 2003;89(1):71-85.
Althaf AS, Seshadri T. Design and study of lamivudine oral sustained release tablets, Pelagia research library. Der Pharm Sin 2010;1(2):61-76.
Chavda Y, Bhimani B, Patel U, Shah R, Patel G, Daslaniya D.
Preparation and evaluation of lamivudine microspheres with Eudragit® polymers by solvent evaporation method For lymphatic system. Int J Pharm Res Biosci 2003;2(3):89-106.
Dey S, Roy N, Mazumdar B. Effect of formulation and process variables on the characteristics of microspheres of antiviral drug (stavudine) prepared by oil-in-oil solvent evaporation technique. Int J Pharm Pharm Sci 2010;2(2):52-9.13. Gibaud S, Bonneville A, Astier A. Preparation of 3, 4-diaminopyridine microparticles by solvent-evaporation methods. Int J Pharm 2002;242(1-2):197-201.
Josephine LJ, Madhusudhan NT, Wilson B, Manjula D, Savitha BK. Formulation and characterization of ritonavir loaded ethyl cellulose microspheres for oral delivery. World J Pharm Res 2012;1(2):207-15.
Jayan SC, Sandeep AV, Rifas M, Mareema CM, Shamseera S. Design and in-vitro evaluation of gelatin microspheres of salbutamol sulphate. Hygeia J D Med 2009;1(1):17-20.
Karthikeyan K, Durgadevi R, Saravanan K, Shivsankar K, Usha S, Saravanan M. Formulation of bioadhesive carbomer gel incorporating drug-loaded gelatin microspheres for periodontal therapy. Trop J Pharm Res 2012;11(3):335-43.
Nath B, Nath LK, Kumar P. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS100, RL100 and their combinations. Acta Pol Pharm Drug Res 2011;68(3):409-15.
Pradeep B, Nagamadhu M. Formulation and evaluation of valaciclovir hydrochloride microcapsules. Int J Pharm Pharm Sci 2011;3(2):92-6.
Shankar NB, Kumar NU. Lamivudine loaded microspheres for oral use: Design, development and establishment of in vivo-in vitro correlation. Asian J Pharm Clin Res 2009;2(1):55-60.
Pandit V, Pai RS, Yadav V, Devi K, Surekha BB, Inamdar MN, et al. Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. Drug Dev Ind Pharm 2013;39(1):117-27.
Rao RN, Prakash K. Preparation and evaluation of lamivudine microspheres using various cellulose polymers. Int J Pharm Tech 2011;3(1):1397-410.
Ikam VK, Gudsoorkar VR, Dolas RT, Somwanshi SB, Gaware VM, Kotade KB, et al. Microspheres: A novel drug delivery system an overview. Pharmacologyonline 2011;3:352-75.
Pavanveena C, Kavitha K, Anil Kumar SN. Formulation and evaluation of trimetazidine hydrochloride loaded chitosan microspheres. Int J Appl Pharm 2010;2(2):11-4.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
